Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases.

Tytuł:
An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases.
Autorzy:
Pogačnik L; Department of Food Science, Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, 1000 Ljubljana, Slovenia.
Ota A; Department of Food Science, Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, 1000 Ljubljana, Slovenia.
Ulrih NP; Department of Food Science, Biotechnical Faculty, University of Ljubljana, Jamnikarjeva 101, 1000 Ljubljana, Slovenia.
Źródło:
Cells [Cells] 2020 Feb 28; Vol. 9 (3). Date of Electronic Publication: 2020 Feb 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
MeSH Terms:
Dietary Supplements/*standards
Neurodegenerative Diseases/*prevention & control
Ubiquinone/*analogs & derivatives
Humans ; Ubiquinone/pharmacology ; Ubiquinone/therapeutic use
References:
Prog Neurobiol. 2017 Aug;155:120-148. (PMID: 26542398)
J Alzheimers Dis Rep. 2019 Nov 21;3(1):279-297. (PMID: 31867567)
Cardiovasc Psychiatry Neurol. 2012;2012:942981. (PMID: 22928089)
Curr Opin Drug Discov Devel. 2010 Mar;13(2):235-46. (PMID: 20205057)
Biomed Pharmacother. 2017 Jan;85:635-645. (PMID: 27890431)
Mol Cell Neurosci. 2013 Jul;55:101-14. (PMID: 23220289)
Front Pharmacol. 2018 Nov 20;9:1261. (PMID: 30524273)
Phytochemistry. 2012 Dec;84:102-15. (PMID: 22954731)
Drug Des Devel Ther. 2016 Mar 10;10:1101-10. (PMID: 27022248)
J Neurosci Res. 2008 Feb 1;86(2):403-10. (PMID: 17929310)
Pharmacology. 2007;79(1):17-26. (PMID: 17135773)
Neural Regen Res. 2018 Jun;13(6):955-961. (PMID: 29926816)
Front Aging Neurosci. 2015 Apr 21;7:52. (PMID: 25954194)
Innate Immun. 2014 Apr;20(3):249-60. (PMID: 23764428)
Eur J Pharmacol. 2014 May 5;730:116-24. (PMID: 24631255)
J Clin Biochem Nutr. 2012 Sep;51(2):122-7. (PMID: 22962530)
Arch Neurol. 2000 Jun;57(6):824-30. (PMID: 10867779)
Neurobiol Aging. 2001 Nov-Dec;22(6):993-1005. (PMID: 11755008)
Lancet Neurol. 2006 Jun;5(6):525-35. (PMID: 16713924)
Arzneimittelforschung. 2007;57(1):4-11. (PMID: 17341003)
J Phys Chem A. 2013 Mar 14;117(10):2082-92. (PMID: 23418927)
J Neurosci. 2005 Sep 21;25(38):8807-14. (PMID: 16177050)
Indian J Physiol Pharmacol. 2005 Oct-Dec;49(4):395-402. (PMID: 16579392)
J Immunol. 2002 May 1;168(9):4701-10. (PMID: 11971020)
Brain Res. 2016 Nov 15;1651:17-26. (PMID: 27639810)
Phytother Res. 2014 Feb;28(2):179-86. (PMID: 23512787)
Curr Med Chem. 2003 Oct;10(19):1917-21. (PMID: 12871093)
Int J Mol Sci. 2014 Jan 22;15(1):1625-46. (PMID: 24451142)
Nutrients. 2018 May 22;10(5):. (PMID: 29789466)
Expert Rev Neurother. 2015 Jan;15(1):41-52. (PMID: 25418871)
J Neuroimmune Pharmacol. 2013 Mar;8(1):356-69. (PMID: 23325107)
Adv Nutr. 2018 Jan 1;9(1):41-50. (PMID: 29438458)
Biomed Res Int. 2014;2014:606928. (PMID: 24860828)
Neurochem Res. 2014 Apr;39(4):707-18. (PMID: 24549762)
Mol Psychiatry. 2000 Nov;5(6):616-32. (PMID: 11126392)
Molecules. 2013 Nov 27;18(12):14726-38. (PMID: 24288000)
Molecules. 2017 Jan 19;22(1):. (PMID: 28106854)
N Engl J Med. 2003 Apr 3;348(14):1356-64. (PMID: 12672864)
Clin Chim Acta. 2018 Oct;485:79-87. (PMID: 29940147)
Drug Metab Rev. 2001 Aug-Nov;33(3-4):255-71. (PMID: 11768769)
Biochim Biophys Acta. 2013 Apr;1830(4):2872-81. (PMID: 23295967)
Exp Mol Med. 2015 Mar 13;47:e151. (PMID: 25766620)
Antioxidants (Basel). 2017 Sep 26;6(4):. (PMID: 28954417)
Foods. 2017 Oct 22;6(10):. (PMID: 29065496)
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jan;25(1):27-57. (PMID: 11263756)
J Neurosci Res. 1994 Jan;37(1):92-6. (PMID: 7908343)
Neurobiol Aging. 2004 Jul;25(6):795-806. (PMID: 15165704)
Cancer Prev Res (Phila). 2009 Jun;2(6):514-7. (PMID: 19470792)
Rejuvenation Res. 2012 Jun;15(3):322-33. (PMID: 22524206)
Integr Med Insights. 2015 Nov 09;10:1-9. (PMID: 26604665)
Biofactors. 2010 Sep-Oct;36(5):370-6. (PMID: 20848560)
J Neurosci Res. 2006 Aug 1;84(2):398-408. (PMID: 16634066)
Neurochem Int. 2013 Mar;62(4):379-88. (PMID: 23391521)
Front Biosci (Landmark Ed). 2014 Jan 01;19:619-33. (PMID: 24389208)
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7710-5. (PMID: 20385841)
J Am Geriatr Soc. 2015 May;63(5):938-46. (PMID: 25919574)
Neurotox Res. 2018 Apr;33(3):656-670. (PMID: 29427283)
J Clin Med. 2019 Nov 06;8(11):. (PMID: 31698718)
Int J Mol Sci. 2019 Jan 16;20(2):. (PMID: 30654461)
Int J Geriatr Psychiatry. 2014 Oct;29(10):1087-95. (PMID: 24633934)
Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S. (PMID: 15640486)
Int J Mol Med. 2013 Apr;31(4):825-32. (PMID: 23426728)
J Neurosci Res. 2004 Mar 15;75(6):742-50. (PMID: 14994335)
Sci Rep. 2017 Dec 20;7(1):17945. (PMID: 29263416)
Expert Rev Neurother. 2010 May;10(5):729-45. (PMID: 20420493)
J Neuroinflammation. 2007 Oct 10;4:25. (PMID: 17927823)
J Neurochem. 2004 Mar;88(6):1555-69. (PMID: 15009657)
Pharmacol Biochem Behav. 2014 Feb;117:92-103. (PMID: 24345573)
Amino Acids. 2013 Aug;45(2):327-38. (PMID: 23645386)
Eur J Pharmacol. 2004 Apr 5;489(1-2):39-48. (PMID: 15063153)
Eur J Nutr. 2019 Feb;58(1):113-130. (PMID: 29151137)
J Nutr. 2009 Oct;139(10):1987-93. (PMID: 19656855)
Neuropharmacology. 2014 Apr;79:380-8. (PMID: 24333330)
Phytother Res. 2014 Apr;28(4):611-6. (PMID: 23857913)
Neurotherapeutics. 2008 Jul;5(3):377-80. (PMID: 18625448)
Biochim Biophys Acta. 2014 Jul;1842(7):902-15. (PMID: 24582596)
J Formos Med Assoc. 2016 Jan;115(1):3-10. (PMID: 26220908)
Biochemistry. 2010 Sep 21;49(37):8127-33. (PMID: 20707388)
PLoS One. 2013 Apr 08;8(4):e60654. (PMID: 23593274)
Int Clin Psychopharmacol. 2003 Mar;18(2):61-71. (PMID: 12598816)
Arch Med Res. 2014 Nov;45(8):610-38. (PMID: 25481827)
J Immunol. 2004 Nov 1;173(9):5794-800. (PMID: 15494532)
Neurotherapeutics. 2008 Jul;5(3):381-90. (PMID: 18625449)
Neural Regen Res. 2017 Apr;12(4):582-583. (PMID: 28553336)
Chem Biol Interact. 2013 Nov 25;206(2):239-47. (PMID: 24095822)
Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):105-14. (PMID: 22727983)
Front Aging Neurosci. 2016 Mar 04;8:38. (PMID: 26973513)
J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67. (PMID: 22051327)
Antioxid Redox Signal. 2013 May 10;18(14):1818-92. (PMID: 22794138)
BMC Med. 2009 Feb 19;7:7. (PMID: 19228370)
Brain Res. 2001 Jan 19;889(1-2):181-90. (PMID: 11166702)
Molecules. 2019 Aug 13;24(16):. (PMID: 31412624)
Neurosci Lett. 2002 Sep 6;329(3):334-8. (PMID: 12183043)
Brain Res. 2013 Jul 26;1523:1-9. (PMID: 23747813)
Eur J Pharmacol. 2011 Sep;668 Suppl 1:S50-8. (PMID: 21816146)
Biochim Biophys Acta. 2012 Nov;1818(11):2502-10. (PMID: 22634381)
N Engl J Med. 1998 Oct 8;339(15):1044-53. (PMID: 9761807)
Antioxidants (Basel). 2020 Jan 10;9(1):. (PMID: 31936711)
Sci Rep. 2018 May 29;8(1):8337. (PMID: 29844450)
Nat Prod Rep. 2009 Aug;26(8):1001-43. (PMID: 19636448)
FEBS Lett. 2011 Apr 20;585(8):1113-20. (PMID: 21443877)
Mol Neurobiol. 2016 Aug;53(6):4094-4125. (PMID: 26198567)
J Food Sci. 2008 Jan;73(1):R14-9. (PMID: 18211362)
J Exp Med. 1999 Feb 15;189(4):615-25. (PMID: 9989976)
Eur J Pharmacol. 2016 Aug 15;785:187-206. (PMID: 26036964)
Front Neurosci. 2019 Jul 24;13:728. (PMID: 31396030)
Neuroscience. 2013 Apr 16;236:136-48. (PMID: 23357119)
Front Pharmacol. 2018 Apr 27;9:422. (PMID: 29755356)
J Toxicol Sci. 2013 Feb;38(1):25-33. (PMID: 23358137)
Neuropsychopharmacology. 2012 Jan;37(1):213-46. (PMID: 21956442)
Cell Mol Neurobiol. 2013 Oct;33(7):929-42. (PMID: 23868340)
Altern Ther Health Med. 2001 Sep-Oct;7(5):70-86, 88-90. (PMID: 11565403)
Prog Neurobiol. 2014 Jan;112:24-49. (PMID: 24211851)
Clin Exp Pharmacol Physiol. 2012 Mar;39(3):265-73. (PMID: 22229384)
Drug Des Devel Ther. 2015 Dec 21;10:23-42. (PMID: 26730179)
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):29-41. (PMID: 16170386)
J Neurochem. 2007 Aug;102(4):1095-104. (PMID: 17472706)
Physiol Rev. 2001 Apr;81(2):741-66. (PMID: 11274343)
J Alzheimers Dis. 2013;37(2):367-77. (PMID: 23948889)
Oxid Med Cell Longev. 2018 Mar 25;2018:8613209. (PMID: 29765505)
Nutrients. 2016 Jan 05;8(1):. (PMID: 26742071)
Cell Mol Neurobiol. 2015 Apr;35(3):323-333. (PMID: 25377066)
Pharmacopsychiatry. 2012 Mar;45(2):41-6. (PMID: 22086747)
Neurochem Res. 2007 Jun;32(6):981-7. (PMID: 17401679)
Phytochem Rev. 2010 Sep;9(3):357-378. (PMID: 20835385)
Redox Biol. 2014 Jan 10;2:187-95. (PMID: 24494192)
J Neurochem. 2010 Mar;112(6):1415-30. (PMID: 20050972)
Curr Pharm Biotechnol. 2014;15(4):318-29. (PMID: 24938890)
Pharm Res. 2013 Oct;30(10):2475-84. (PMID: 23135822)
Fitoterapia. 2016 Jul;112:136-43. (PMID: 27233988)
Neuroscience. 2015 Feb 12;286:383-92. (PMID: 25498223)
Mol Nutr Food Res. 2014 Oct;58(10):1931-40. (PMID: 25066301)
Ann N Y Acad Sci. 2011 Jan;1215:9-15. (PMID: 21261636)
J Nutr Biochem. 2005 Oct;16(10):610-6. (PMID: 16081270)
Neurotox Res. 2013 Feb;23(2):166-73. (PMID: 22669749)
Crit Rev Food Sci Nutr. 2020;60(4):597-625. (PMID: 30614258)
Neurotherapeutics. 2010 Oct;7(4):413-23. (PMID: 20880505)
Biofactors. 1999;9(2-4):261-6. (PMID: 10416039)
N Engl J Med. 2006 Feb 9;354(6):610-21. (PMID: 16467548)
Autophagy. 2014 Mar;10(3):524-5. (PMID: 24419144)
J Neurosci. 2012 Oct 10;32(41):14311-7. (PMID: 23055502)
Nutrients. 2011 Aug;3(8):735-55. (PMID: 22254121)
Neurobiol Dis. 2019 Apr;124:505-519. (PMID: 30610916)
J Altern Complement Med. 2005 Jun;11(3):521-8. (PMID: 15992239)
Int J Mol Sci. 2018 May 31;19(6):. (PMID: 29857538)
Front Biosci (Landmark Ed). 2016 Jun 01;21:1314-29. (PMID: 27100509)
Biofactors. 2013 Jan-Feb;39(1):122-32. (PMID: 23303664)
Nutr Neurosci. 2015 May;18(4):169-76. (PMID: 24621064)
Arch Neurol. 2002 Oct;59(10):1541-50. (PMID: 12374491)
Chin J Nat Med. 2014 Oct;12(10):777-81. (PMID: 25443371)
J Neurosci. 2001 Nov 1;21(21):8370-7. (PMID: 11606625)
PLoS One. 2015 Dec 16;10(12):e0143625. (PMID: 26674103)
Eur J Pharmacol. 2015 Mar 5;750:74-81. (PMID: 25637088)
Biochim Biophys Acta. 2015 Jun;1852(6):1071-113. (PMID: 25652123)
Int J Mol Sci. 2019 Apr 16;20(8):. (PMID: 30995776)
Brain Res. 2013 Jun 23;1517:28-35. (PMID: 23603411)
Biochim Biophys Acta. 2013 Nov;1828(11):2532-43. (PMID: 23817009)
J Neurosci Res. 2014 Jan;92(1):130-9. (PMID: 24166733)
Parkinsons Dis. 2014;2014:262058. (PMID: 25538856)
Daru. 2014 Apr 11;22:38. (PMID: 24726284)
Nat Prod Res. 2014;28(10):746-52. (PMID: 24499319)
Int J Vitam Nutr Res. 2004 Jul;74(4):269-78. (PMID: 15580809)
BMC Complement Altern Med. 2012 Jun 28;12:82. (PMID: 22742579)
Front Biosci (Schol Ed). 2012 Jan 01;4:581-98. (PMID: 22202078)
J Nutr. 2011 May;141(5):989S-1009S. (PMID: 21451125)
Curr Opin Clin Nutr Metab Care. 2015 Mar;18(2):139-46. (PMID: 25501348)
J Biol Chem. 2005 Nov 11;280(45):37377-82. (PMID: 16162502)
Evid Based Complement Alternat Med. 2014;2014:940186. (PMID: 25002904)
J Pharm Health Care Sci. 2015 Apr 10;1:14. (PMID: 26819725)
Neurosci Lett. 2013 Oct 25;555:106-11. (PMID: 24045063)
Contributed Indexing:
Keywords: dietary phytochemicals; endogenous substances; mitochondrial dysfunction; neurodegenerative diseases; neuroinflammation; oxidative stress; protein fibrillation
Substance Nomenclature:
1339-63-5 (Ubiquinone)
EJ27X76M46 (coenzyme Q10)
Entry Date(s):
Date Created: 20200304 Date Completed: 20210311 Latest Revision: 20210311
Update Code:
20240105
PubMed Central ID:
PMC7140513
DOI:
10.3390/cells9030576
PMID:
32121302
Czasopismo naukowe
Neurodegenerative diseases, namely Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis are becoming one of the main health concerns due to the increasing aging of the world's population. These diseases often share the same biological mechanisms, including neuroinflammation, oxidative stress, and/or protein fibrillation. Recently, there have been many studies published pointing out the possibilities to reduce and postpone the clinical manifestation of these deadly diseases through lifelong consumption of some crucial dietary substances, among which phytochemicals (e.g., polyphenols) and endogenous substances (e.g., acetyl-L-carnitine, coenzyme Q10, n-3 poysaturated fatty acids) showed the most promising results. Another important issue that has been pointed out recently is the availability of these substances to the central nervous system, where they have to be present in high enough concentrations in order to exhibit their neuroprotective properties. As so, such the aim of this review is to summarize the recent findings regarding neuroprotective substances, their mechanisms of action, as well as to point out therapeutic considerations, including their bioavailability and safety for humans.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies